We are delighted to present the New Thought Leaders Clinical Research and Treatment in Lupus: 2023 article collection. This collection showcases the high-quality work of internationally recognized researchers in the early stages of their independent careers.
All new thought leaders researchers were individually nominated by the Frontiers in Lupus editors in recognition of their potential to influence the future directions in their respective fields. The work presented here highlights the diversity of research performed across the entire breadth of Clinical Research and Treatment in Lupus and presents advances in theory, experiment, and methodology with applications to compelling problems.
New articles will be added to this collection as they are published. Please note that contributions are decided by topic editors only. Please inform topic editors when you wish to submit a manuscript. Early career researchers are defined as within 10 years after completing their Ph.D., M.D., or other equivalent terminal degrees.
Dr. David Pearson is/has been a recent clinical trials investigator for EMD Serono, Priovant, Daiichi Sankyo, Pfizer, Incyte, Emerald Health, Kadmon, and Argenx within the past 3 years. They are also a consultant for Biogen, Pfizer, and Merck.
Keywords:
Lupus, Early Career Researchers in Clinical Research and Treatment in Lupus, Rising Stars in Early Career Researchers in Clinical Research and Treatment in Lupus, Clinical Research in Lupus, Treatment in Lupus
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
We are delighted to present the New Thought Leaders Clinical Research and Treatment in Lupus: 2023 article collection. This collection showcases the high-quality work of internationally recognized researchers in the early stages of their independent careers.
All new thought leaders researchers were individually nominated by the Frontiers in Lupus editors in recognition of their potential to influence the future directions in their respective fields. The work presented here highlights the diversity of research performed across the entire breadth of Clinical Research and Treatment in Lupus and presents advances in theory, experiment, and methodology with applications to compelling problems.
New articles will be added to this collection as they are published. Please note that contributions are decided by topic editors only. Please inform topic editors when you wish to submit a manuscript. Early career researchers are defined as within 10 years after completing their Ph.D., M.D., or other equivalent terminal degrees.
Dr. David Pearson is/has been a recent clinical trials investigator for EMD Serono, Priovant, Daiichi Sankyo, Pfizer, Incyte, Emerald Health, Kadmon, and Argenx within the past 3 years. They are also a consultant for Biogen, Pfizer, and Merck.
Keywords:
Lupus, Early Career Researchers in Clinical Research and Treatment in Lupus, Rising Stars in Early Career Researchers in Clinical Research and Treatment in Lupus, Clinical Research in Lupus, Treatment in Lupus
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.